Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes

41Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bactericidal/permeability-increasing protein (BPI), a cationic protein present in the azurophilic granule and on the surface of polymorphonuclear leukocytes, specifically interacts with lipopolysaccharide (LPS). This study demonstrates for the first time, using flow cytometry with specific anti-BPI monoclonal antibody (MAb), that human peripheral blood monocytes express BPI on their cell surface. The monocyte cell surface BPI was shown to bind to LPS, because binding of anti-BPI MAb 4E3 (which is known not to react with BPI to which LPS is bound) to cell surface BPI was strongly reduced after preincubation of cells with LPS. However, cell surface BPI did not quantitatively contribute to the interaction of LPS with the monocyte cell membrane, since preincubation of cells with 4E3 did not block binding of LPS-fluorescein isothiocyanate to monocytes. The origin of the monocyte cell surface BPI remains to be further elucidated. © 1996 by The University of Chicago. All rights reserved.

Cite

CITATION STYLE

APA

Dentener, M. A., Francot, G. J. M., & Buurman, W. A. (1996). Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. Journal of Infectious Diseases, 173(1), 252–255. https://doi.org/10.1093/infdis/173.1.252

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free